by Andreu Prados
A new review focuses on mechanisms leading to increased susceptibility to bacterial infection in the context of interactions between dietary transition metals,
by Paul Enck
A new double-blinded randomized study has found that rifaximin—a poorly absorbable antibiotic acting mainly in the gut —may exhibit stress-reducing effects by modulating our gut microbiota in a way similar to probiotics.
by Andreu Prados
A new study has found that microbiota-accessible carbohydrate-utilizing bacteria and short-chain fatty acids generated during their fermentation prevent C. difficile infection perpetuation in mice.
by Andreu Prados
A recent study has found that many non-antibiotic human-targeted drugs may have a direct effect on the gut microbiome that potentially contribute to both their gastrointestinal side effects and therapeutic actions.
by GMFH Editing Team
The document below features exclusive GMFH content and is intended to serve as a key resource for health professionals.
by GMFH Editing Team
The functional gastrointestinal disorders (FGIDs) that are characterized by persistent and recurring GI symptoms.
by GMFH Editing Team
The scientific knowledge on probiotics is advancing very quickly—stay tuned for the second GMFH "best of probiotics" document.
A scientific committee chaired has taken care to put together a program that covers the most relevant issues in the field today.
by Andreu Prados
A recent study has found that a particular gut microbe modulates immune response to influenza infection in mice through breaking down flavonoids naturally found in vegetal foods.
by Paul Enck
A new community-based, double-blind, placebo-controlled randomized trial has found that a synbiotic consisting of a strain of Lactobacillus plantarum and fructooligosaccharide may be effective in preventing sepsis in rural Indian newborns.
